In this episode of The End Game Podcast, host Melissa Butterworth interviews Emily Johnson, a healthcare regulatory partner at McDonald Hopkins. They discuss recent regulatory and enforcement actions impacting laboratories and pathology groups. Emily highlights the recent enforcement trends and how labs and pathology groups can prevent an investigation and what to do if they do get investigated. She also discusses the impact of investigations on the ability to sell a business and the importance of proactive preparation for due diligence.

 In this episode, Melissa delves into a critical topic for laboratory owners: the strategic choices between selling independently versus engaging a business banker or M&A advisory firm. 

Choosing the right path for selling your laboratory can be a game-changer. Melissa expertly dissects the advantages and disadvantages of both approaches, providing invaluable guidance for navigating this pivotal decision. 

Whether you're weighing the benefits of maintaining full control over the selling process or seeking the expertise and connections of professionals, Melissa's insights offer a roadmap for success. Don't miss out on this essential discussion that could shape the future of your laboratory business.

In this episode, Melissa Butterworth discusses the concept of due diligence in M&A transactions. Melissa covers various areas that are examined during due diligence, including financials, incorporation documents, employee benefits, compliance programs, customer contracts, intellectual property, and more. She also provides recommendations on what not to share during due diligence and advises against non-simultaneous sign and close arrangements.

In this week's episode, Melissa Butterworth interviews Jeff Myers, Vice President of Consulting and Strategic advisory services for Accumen. They discuss the importance of understanding lab test complexity in both acute care and ambulatory lab testing settings. They also discuss the importance of department-level reporting for lab costs and lab volume as well as building a Laboratory Relative Value Unit (RVU) system. They explore the relationship between lab test mix and hospital case mix index.

In this podcast episode, Jim Billington, CEO and co-founder of Versant Diagnostics, discusses the impact of digital pathology on the laboratory diagnostic landscape. He shares his background and the founding of Versant Diagnostics, highlighting the mission to drive the adoption of digital pathology for better patient outcomes. 

In this episode, Melissa Butterworth and Rick Cooper discuss hospital lab transactions and key negotiation must-haves. They highlight the current appetite for hospital lab transactions and the reasons why hospitals are selling labs or seeking management agreements. They emphasize the importance of negotiating protections for quality lab services and the use of performance metrics as protection in hospital deals. They also discuss the problems that can arise post-transaction and the causes behind them. The episode concludes with final thoughts on assessing the marketplace and making informed decisions.

In this episode, Melissa Butterworth discusses the differences between asset and stock transactions in lab M&A deals and how they can affect valuation. She also explains the two types of buyers in the market: strategic buyers and non-strategic buyers. Strategic buyers are more likely to pay maximum value for a lab due to the synergies they can recognize between their entity and the one being sold. On the other hand, non-strategic buyers may pay based on a standard multiplier of adjusted EBITDA. Melissa emphasizes the importance of a competitive process in negotiating the price and achieving maximum valuation.

In this episode of The Endgame podcast, Melissa Butterworth discusses the seven key attributes that define a quality lab from the eyes of a buyer.  The host provides insights and tips for lab owners who are considering selling their lab, highlighting the importance of these attributes in attracting buyers and increasing the value of the lab.

In this episode of The Endgame podcast, Melissa Butterworth discusses the topic of valuation and how to prepare for maximum valuation when selling a lab. The conversation is divided into 10 key steps that should be implemented or considered prior to selling a lab. 

Welcome to the very first episode of The End Game, a podcast by senior lab executives for senior lab executives. Melissa will dive into the most asked question "What is the value of my laboratory?" and  the five most common valuation methods used.